Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UCSD Team Identifies Potential Role of CRP in Development of Atherosclerosis

10.09.2002


Another piece of the complex puzzle of how inflammation is involved in heart attacks and strokes has been discovered by researchers at the University of California, San Diego (UCSD) School of Medicine.


Mi-Kyung Chang, M.D., first author
© UCSD


Joseph Witztum, M.D., and Mi-Kyung Chang, M.D.
© UCSD



Their findings demonstrate that C-reactive protein (CRP) binds to oxidized low density lipoprotein (LDL), implicating the interaction of CRP and oxidized LDL as a potential trigger for the cascade of events leading to atherosclerosis. This form of artery disease is characterized by the buildup of fatty deposits and chronic inflammation along the artery wall, eventually leading to heart attack.

Published in the online edition of Proceedings of the National Academy of Sciences (PNAS) the week of Sept. 9, 2002, the study by the UCSD researchers pinpoints how CRP attaches itself to oxidized LDL, the so-called "bad cholesterol" that accumulates in the artery wall and generates atherosclerotic plaques. LDL is the major cholesterol carrying particles. When they enter the artery wall from the circulation, they are believed to be modified by oxidation. It is this "oxidized LDL" that is thought to be the culprit leading to inflammation and cholesterol accumulation.


"Our study points out that CRP is not merely a marker of future cardiovascular events, as most people believe, but it actually binds to oxidized LDL and apoptotic or dying cells, giving it a potential role in development or modulation of atherosclerosis, as well as in other inflammatory disease," said Mi-Kyung Chang, M.D., an assistant project scientist and the first author of the paper in PNAS.

In the new studies, the UCSD team showed that CRP binds to oxidized LDL through the recognition of phosphocholine, a part of an oxidized molecule on the surface that is exposed when LDL undergoes oxidation.

Noting that there is an accumulation of dead and dying cells (apoptotic cells) in atherosclerotic lesions and that these cells are under increased oxidative stress, the UCSD researchers also determined that CRP binds to these cells in a similar manner as it recognizes oxidized LDL.

CRP is conventionally regarded as a first-line defense of the immune system against invading pathogens and confers protection to humans by removing pathogens. Recently, CRP has been reported as a useful marker for predicting future atherosclerotic cardiovascular events, but the basis for this correlation remains unclear.

Although scientists still do not understand all the steps in the development of atherosclerosis, it is known that oxidized LDL in the artery wall are taken up (engulfed) by macrophages, scavenger cells that have been drawn to the site by oxidized LDL. When they become engorged with the oxidized LDL, the macrophages become "foam cells," the hallmark of atherosclerotic plaques. It is possible that CRP may bind to oxidized LDL and further enhance the uptake into cells.

The paper’s senior author, Joseph Witztum, M.D., professor of medicine, added that cholesterol is still a key player in coronary heart disease. He said that CRP may be working in its "correct role" as part of the immune response to the toxic oxidized LDL and may help promote its clearance.

"If you have low levels of LDL, and thus, low levels of oxidized LDL, then CRP may be of benefit," Witztum said. "However, when there is an overwhelming accumulation of LDL, and thus oxidized LDL, in its attempt to help clear the toxic particle, the CRP may actually make things worse. It may cause more oxidized LDL to be taken up into macrophage scavenger cells, which in turn cause cholesterol accumulation – a sort of ’Trojan horse’."

For the past 20 years, the Witztum lab at UCSD, in collaboration with UCSD professor of medicine Daniel Steinberg, M.D., Ph.D., has pioneered the role of oxidized LDL as a major contributing factor for the development of atherosclerosis. In particular, the Witztum lab has been studying immunological response to oxidized LDL and its impact on development and modulation of atherosclerosis. Recently, the Witztum team found that many mouse antibodies that are specific to oxidized LDL are identical to "T15" type natural antibodies that have been extensively studied for 30 years by immunologists for their recognition of S. pneumoniae, the most common cause of pneumonia. T15 also binds to phosphocholine present on pathogens and provides a protective immune defense against those pathogens.

As both T15 antibody and CRP recognize the same molecule, phosphocholine, Chang reasoned that CRP might bind to oxidized LDL, but not native LDL that does not expose phosphocholine. Indeed, Chang and colleagues showed that CRP does bind to oxidized LDL as well as apoptotic cells through the recognition of phosphocholine. Therefore, CRP is now a novel immune response to oxidized LDL, along with macrophages and T15 antibodies, through the recognition of the same phosphocholine molecule, which is also present on many infectious pathogens.

Studies are now underway to determine whether CRP is protective, or could actually cause harm.

The UCSD research was funded by the National Institutes of Health. In addition to Chang and Witztum, additional authors were Christoph J. Binder, Ph.D., post doctoral fellow, and Michael Torzewski, M.D., visiting scholar, UCSD Department of Medicine.

University of California - San D | EurekAlert!
Further information:
http://health.ucsd.edu/news/

More articles from Health and Medicine:

nachricht GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University

nachricht Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: BAM@Hannover Messe: innovative 3D printing method for space flight

At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.

Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...

Im Focus: Molecules Brilliantly Illuminated

Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.

Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Getting electrons to move in a semiconductor

25.04.2018 | Physics and Astronomy

Reconstructing what makes us tick

25.04.2018 | Physics and Astronomy

Cheap 3-D printer can produce self-folding materials

25.04.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>